Y Intercept Hong Kong Ltd lifted its position in shares of Maximus, Inc. (NYSE:MMS – Free Report) by 198.8% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 69,073 shares of the health services provider’s stock after acquiring an additional 45,953 shares during the quarter. Y Intercept Hong Kong Ltd owned approximately 0.13% of Maximus worth $4,428,000 at the end of the most recent reporting period.
Several other large investors have also made changes to their positions in the company. Farther Finance Advisors LLC increased its position in Maximus by 69.0% in the fourth quarter. Farther Finance Advisors LLC now owns 284 shares of the health services provider’s stock worth $25,000 after purchasing an additional 116 shares during the period. Advisory Services Network LLC acquired a new position in Maximus during the 3rd quarter valued at about $32,000. Canada Pension Plan Investment Board acquired a new position in Maximus during the 2nd quarter valued at about $35,000. Northwestern Mutual Wealth Management Co. boosted its stake in shares of Maximus by 225.2% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 439 shares of the health services provider’s stock valued at $38,000 after purchasing an additional 304 shares during the last quarter. Finally, Richardson Financial Services Inc. boosted its stake in shares of Maximus by 29.6% in the 4th quarter. Richardson Financial Services Inc. now owns 451 shares of the health services provider’s stock valued at $39,000 after purchasing an additional 103 shares during the last quarter. Institutional investors and hedge funds own 97.21% of the company’s stock.
Maximus Stock Performance
MMS stock opened at $55.80 on Monday. The company has a current ratio of 2.21, a quick ratio of 2.21 and a debt-to-equity ratio of 0.87. The business’s 50-day moving average price is $60.38 and its two-hundred day moving average price is $72.80. Maximus, Inc. has a 1-year low of $52.73 and a 1-year high of $100.00. The firm has a market cap of $2.93 billion, a PE ratio of 8.35 and a beta of 0.60.
Wall Street Analysts Forecast Growth
A number of equities research analysts recently weighed in on MMS shares. Weiss Ratings downgraded shares of Maximus from a “hold (c)” rating to a “hold (c-)” rating in a research note on Wednesday, May 20th. Zacks Research cut shares of Maximus from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 27th. Finally, Wall Street Zen raised shares of Maximus from a “hold” rating to a “buy” rating in a report on Saturday, June 6th. Two analysts have rated the stock with a Hold rating, According to data from MarketBeat, the company currently has a consensus rating of “Hold”.
Get Our Latest Research Report on Maximus
Maximus Profile
Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.
Read More
- Five stocks we like better than Maximus
- Visa’s Open USD Push Puts Circle’s Stablecoin Moat Under Pressure
- This Under-the-Radar Industrial Is Quietly Powering AI
- Why Microsoft Looks Like the Best Big Tech Trade for H2 2026
- Strategy’s Bitcoin Pivot Gives Investors a New Reason to Watch Preferred Shares
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS – Free Report).
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.
